INPUT_MISSING: [MISSING] No A/B test scenario provided (no baseline conversion rate, no MDE target, no sample size, no alpha/beta levels, no observed data).
PARTIAL ANALYSIS — COMPARISON TABLE (method disambiguation placeholder)
METHOD: O'Brien-Fleming vs Pocock sequential boundaries
Property                O'Brien-Fleming            Pocock
Stopping rule           Conservative early,        Constant critical value
                        aggressive late            across all looks
Alpha spending          Very little alpha spent    Alpha evenly divided
                        at early looks             across looks
Critical value (5 looks) Z_1 ~ 4.56 -> 2.00       Z_all ~ 2.41
Power penalty           Minimal (~1% loss)         Moderate (~3-5% loss)
Correction stringency   Very strict early,         Uniformly strict
                        lenient late               across looks
Best use case           Large effects uncertain    Small effects, few looks,
                        at start, many looks       equal importance each look
SELECTION: O'Brien-Fleming
RATIONALE: When the number of interim looks is high (>=5) and early stopping for large effects is acceptable, O'Brien-Fleming preserves more overall power and spends less alpha at early looks, giving the effect time to stabilize.
RULES OUT: Pocock — Pocock uses a constant critical boundary (e.g. Z=2.41 for 5 looks) across all interim analyses, which spends alpha aggressively at the first look and reduces overall power compared to O'Brien-Fleming at the same total alpha. If a fixed-horizon test were required instead of sequential, a standard z-test would apply.
FORMULA VERIFICATION: [MISSING] No numeric scenario provided. Placeholder values below for demonstration.
Canonical form (O'Brien-Fleming boundary, 5 looks, alpha=0.05):
  OBrienFleming alpha_i = 2 * (1 - Phi(Z_alpha/2 / sqrt(i/k)))
  Where k = 5 looks, i = look index (1..5), Phi = standard normal CDF
  Boundary derivation: Lan-DeMets (1983) approximation to O'Brien-Fleming
Reference: O'Brien, P. C. & Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics, 35(3), 549-556.
Secondary: Lan, K. K. G. & DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika, 70(3), 659-663.
No reverse-check performed — [MISSING] numeric inputs for substitution.
CI DECOMPOSITION: [MISSING] No point estimate or SE provided.
REVIEW PHASE: [MISSING] Cannot complete numerical consistency checks without base inputs.
ALTERNATIVES FOR COMPLETION:
1. Paste your A/B test scenario (baseline conversion, MDE, n per arm, alpha, beta, observed results)
2. I can read a scenario file from a path you provide
3. Example scenario format:
   baseline: 0.10 (10% conversion)
   mde: 0.02 (2 percentage point lift)
   alpha: 0.05 (two-sided)
   beta: 0.20 (80% power)
   looks: 4 interim + 1 final
   method: OBF
   observed_a: 450/5000
   observed_b: 510/5000
[END PARTIAL ANALYSIS]